INIS
animals
100%
nervous system diseases
100%
dopamine
75%
mitochondria
50%
neurons
50%
atp
50%
diseases
25%
levels
25%
reduction
25%
humans
25%
rats
25%
drugs
25%
injection
25%
losses
25%
tyrosine
25%
failures
25%
concentration
25%
rotation
25%
anatomy
25%
transport
25%
gold
25%
hydroxylase
25%
respiration
25%
shrinkage
25%
dopa
25%
Keyphrases
Parkinson's Disease
100%
New Animal Model
100%
Neuronal Dysfunction
100%
Aminochrome
100%
Dopamine Release
33%
Striatum
33%
Dopaminergic Neurons
33%
Monoaminergic
33%
Substantia Nigra
16%
ATP Level
16%
Dopamine
16%
Apomorphine
16%
Mitochondrial Damage
16%
Tyrosine Hydroxylase
16%
Parkinsonism
16%
Significant Loss
16%
Neurotoxin
16%
L-DOPA
16%
Cell Shrinkage
16%
Rat Striatum
16%
Synaptic Vesicle
16%
Gold Drugs
16%
Mitochondrial Respiration
16%
GABA Release
16%
Synaptic Vesicle Release
16%
Parkinson's Disease Treatment
16%
Anterograde Transport
16%
Contralateral Rotations
16%
Medicine and Dentistry
Parkinson's Disease
100%
Striatum
75%
Adenosine Triphosphate
50%
Contralateral
50%
Dopamine Release
50%
Dopaminergic Neuron
50%
Disease
25%
Combination Therapy
25%
Mitochondrion
25%
Mitochondrial Respiration
25%
Clinical Study
25%
Gamma-Aminobutyric Acid
25%
Substantia nigra
25%
Synaptic Vesicle
25%
Parkinsonism
25%
Apomorphine
25%
Neurotoxin
25%
Tyrosine 3 Monooxygenase
25%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
25%
Mitochondrial Permeability Transition Pore
25%
Neuroscience
Dopaminergic
100%
Parkinson's Disease
100%
Striatum
75%
Adenosine Triphosphate
50%
Dopaminergic Neuron
50%
Dopamine Release
50%
Behavior (Neuroscience)
25%
Mitochondrion
25%
Mitochondrial Respiration
25%
Tyrosine Hydroxylase
25%
Apomorphine
25%
Gamma-Aminobutyric Acid
25%
Substantia nigra
25%
Parkinsonism
25%
Neurotoxin
25%
Mitochondrial Permeability Transition Pore
25%
Synaptic Vesicle
25%
Biochemistry, Genetics and Molecular Biology
Dopaminergic
100%
Animal Model
100%
Adenosine Triphosphate
66%
Monoaminergic
66%
Dopamine Release
66%
Mitochondrial Respiration
33%
Mitochondrion
33%
Clinical Study
33%
Tyrosine Hydroxylase
33%
Mitochondrial Permeability Transition Pore
33%
Neurotoxin
33%
Gamma-Aminobutyric Acid
33%
Apomorphine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Dopamine Receptor Stimulating Agent
100%
Adenosine Triphosphate
50%
Disease
25%
Clinical Study
25%
Combination Therapy
25%
Neurotoxin
25%
4 Aminobutyric Acid
25%
Parkinsonism
25%
Apomorphine
25%
Tyrosine 3 Monooxygenase
25%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
25%
Mitochondrial Permeability Transition Pore
25%